IL-18Rβ showed a slight increase in patients with severe COPD compared with those with mild/moderate COPD (p=0.045) and control smokers (p=0.039) but did not differ in comparison with control non-smokers. Here, IL18RAP is linked to chronic obstructive pulmonary disease.